Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort

<div>Prevalence of pregnancies exposed to any ADM, an insulin product, a blood glucose-lowering drug, or both an insulin product and a blood glucose-lowering drug, in the GDM group, per calendar year between 2012 and 2019.</div>

Journal of Diabetes Research

fig4

Figure 4

Figure 4: Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort 

Figure 4 | Antidiabetic Medication Utilisation before and during Pregnancy in Switzerland between 2012 and 2019: An Administrative Claim Database from the MAMA Cohort 